APP and Alzheimer disease: The former constitutes 5% of AD cases and is characterized by mutations in the Amyloid Precursor Protein (APP), Presenilin 1 (PSEN1) or Presenilin 2 (PSEN2) genes, all of which are related to the synthesis and processing of Aβ-peptide.